Hearing loss in association with topical imiquimod use for squamous cell carcinoma in situ (Bowen disease)

Australas J Dermatol. 2016 Nov;57(4):323-324. doi: 10.1111/ajd.12470.

Authors

Michelle Rodrigues¹, Sarah E Gamboni², Vincent C Cousins³, Rosemary L Nixon²

Affiliations

¹ Department of Dermatology, St Vincent's Hospital, Melbourne, Victoria, Australia.
² Skin and Cancer Foundation, Occupational Dermatology Research and Education Centre, Melbourne, Victoria, Australia.
³ ENT-Otoneurology Unit, Department of Surgery, Alfred Hospital, Melbourne, Victoria, Australia.

PMID: 27885662
DOI: 10.1111/ajd.12470

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aminoquinolines / adverse effects*
Antineoplastic Agents / adverse effects*
Bowen's Disease / drug therapy*
Carcinoma in Situ / drug therapy*
Female
Hearing Loss, Sensorineural / chemically induced*
Humans
Imiquimod
Skin Neoplasms / drug therapy*

Substances

Aminoquinolines
Antineoplastic Agents
Imiquimod